Related Experiment Video
Updated: Apr 28, 2026
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine
Gervais Rioux, Claudia Mathieu, Alexis Russell
1Department of Microbiology, Infectiology and Immunology, 'Centre de recherche en Infectiologie', Laval University, 2705 boul, Laurier, Quebec City, PQ G1V 4G2, Canada. denis.leclerc@crchudequebec.ulaval.ca.
Background:
Trivalent inactivated flu vaccines (TIV) are currently the best means to prevent influenza infections. However, the protection provided by TIV is partial (about 50%) and it is needed to improve the efficacy of protection. Since the respiratory tract is the main site of influenza replications, a vaccine that triggers mucosal immunity in this region can potentially improve protection against this disease. Recently, PapMV nanoparticles used as an adjuvant in a formulation with TIV administered by the subcutaneous route have shown improving the immune response directed to the TIV and protection against an influenza challenge.
Findings:
In the present study, we showed that intranasal instillation with a formulation containing TIV and PapMV nanoparticles significantly increase the amount of IgG, IgG2a and IgA in lungs of vaccinated mice as compared to mice that received TIV only. Instillation with the adjuvanted formulation leads to a more robust protection against an influenza infection with a strain that is lethal to mice vaccinated with the TIV.
Conclusions:
We demonstrate for the first time that PapMV nanoparticles are an effective and potent mucosal adjuvant for vaccination.
More Related Videos
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
08:01Imaging Cell Interaction in Tracheal Mucosa During Influenza Virus Infection Using Two-photon Intravital Microscopy
Published on: August 17, 2018